Search Results
Tanios Bekaii-Saab, MD: Impact of Third-Line Therapy
mCRC: Options for Third-Line Therapy
Tanios Bekaii-Saab, MD: Fourth-Line Therapy in mCRC
Tanios Bekaii-Saab, MD: Mechanisms of Action in Regorafenib
Third-Line Therapy for Pancreatic Cancer
Tanios Bekaii-Saab, MD: First-Line Treatments in Unresectable Colon Cancer
Tanios Bekaii Saab, MD: Treatment Toxicities and Quality of Life
Tanios Bekaii-Saab, MD: Experience With Patients on Bevacizumab Plus Chemotherapy
Tanios Bekaii-Saab, MD: Clinical Data Supporting Trifluradine-Tipiracil
Tanios Bekaii Saab, MD: RAS Mutations and the Sequence of Therapies
Tanios Bekaii-Saab, MD, comments on dosing regorafenib (Stivarga) in 3rd line treatment of mCRC
Metastatic Colorectal Cancer: Multiple Lines of Therapy
